Immunolight Press Releases

• Published on September 17, 2024 - 22:57 GMT

  

  New Future in Review Conference Podcast Features Immunolight

  Tune into the latest Future in Review (FiRe) podcast episode with Berit Anderson, COO of FiRe, and Harold Walder, President of Immunolight. DURHAM, NC, UNITED STATES, September 17, 2024 /⁨EINPresswire.com⁩/ -- Tune into the latest Future in Review (FiRe) …

  Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...
• Published on August 14, 2024 - 16:04 GMT

  

  X-PACT Is Now Immunolight Cancer Therapy

  A groundbreaking cancer treatment, currently in clinical trial and formerly known as X-PACT, has been rebranded as Immunolight Cancer Therapy (ICT). DURHAM, NC, USA, August 14, 2024 /⁨EINPresswire.com⁩/ -- We are thrilled to announce a significant …

  Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...
• Published on July 16, 2024 - 18:44 GMT

  

  Immunolight Selected to Present at 2024 Future in Review Conference

  The recognition highlights our groundbreaking contributions to the field of medicine, particularly our advancements with Immunolight Cancer Therapy. DURHAM, NORTH CAROLINA, UNITED STATES, July 16, 2024 /⁨EINPresswire.com⁩/ -- Immunolight is excited to …

  Distribution channels: Business & Economy, Companies ...
• Published on June 21, 2023 - 13:15 GMT

  Immunolight, LLC Announces Expansion of its Phase 1 Trial to All Solid Tumor Types

  Immunolight LLC is excited to announce that its X-PACT 101 Phase 1 Clinical Trial is now open to patients with all advanced solid tumor cancers. DURHAM, NORTH CAROLINA, USA, June 21, 2023 /⁨EINPresswire.com⁩/ -- Immunolight LLC, a clinical stage …

  Distribution channels: Healthcare & Pharmaceuticals Industry ...